- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07700407
Preventing Overdose and Promoting Recovery Through Court Navigation (POPCORN)
10 juli 2026 bijgewerkt door: Bradley Ray, RTI International
Hybrid Type I Trial of a Peer-Led Court Navigation Program to Improve Substance Use Disorder Treatment Receipt and Reduce Overdose and Incarceration Among People Passing Through Courthouses
This project is a hybrid type I clinical trial to assess the effectiveness and implementation determinants of a peer-led court navigation program for people who use drugs and are passing through county courthouses.
Courthouses are a common point of contact for people with behavioral health needs, but outside of specialty court models, they remain underexplored as a setting for connecting people to substance use disorder treatment and related services.
This study will test whether court navigation led by peer recovery specialists can increase receipt of substance use disorder treatment and reduce overdose and incarceration.
Peer court navigators will meet with participants in courthouse settings, assess their needs, provide information and referrals, and offer follow-up support for up to 3 months.
Peer recovery specialists, who have lived experience with substance use recovery, are increasingly being integrated into criminal legal and community-based settings; however, peer-led court navigation remains an innovative and understudied approach.
Studie Overzicht
Toestand
Nog niet aan het werven
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Geschat)
600
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studiecontact
- Naam: Bradley Ray, PhD
- Telefoonnummer: 919-324-5492
- E-mail: bradleyray@rti.org
Studie Contact Back-up
- Naam: Cari Megerian, MPH
- Telefoonnummer: 415-412-0830
- E-mail: cmegerian@rti.org
Studie Locaties
-
-
Indiana
-
South Bend, Indiana, Verenigde Staten, 46601
- St. Joseph County Courthouse 1
-
Contact:
- Bradley Ray, PhD
- Telefoonnummer: 919-324-5492
- E-mail: bradleyray@rti.org
-
Contact:
- Cari Megerian, MPH
- Telefoonnummer: 415-412-0830
- E-mail: cmegerian@rti.org
-
-
North Carolina
-
Research Triangle Park, North Carolina, Verenigde Staten, 27709
- RTI International
-
Contact:
- Bradley Ray, PhD
- Telefoonnummer: 919-324-5492
- E-mail: bradleyray@rti.org
-
Contact:
- Cari Megerian, MPH
- Telefoonnummer: 415-412-0830
- E-mail: cmegerian@rti.org
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Nee
Beschrijving
Inclusion Criteria:
- Aged 18 years or older
- Current resident of Indiana
- Able to complete study procedures in English
- Meets at least one of the following criteria: used heroin, fentanyl, methamphetamine, or cocaine in the past 12 months; is interested in resources or treatment for a substance use disorder; or experienced an opioid-related overdose in the past 12 months
Exclusion Criteria:
- Has been sentenced to incarceration in jail or prison for the next 12 months
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Peer court navigation
CourtConnect is the intervention.
It connects individuals in courthouses with peer court navigators who provide information, referrals, and support to address substance use disorder treatment needs and related health and social needs.
Navigation begins in the courthouse and continues in the community through follow-up support for up to 3 months.
|
CourtConnect connects individuals in courthouses with peer court navigators who provide information, referrals, and support to address substance use disorder treatment needs and related health and social needs.
Navigation begins in the courthouse and continues in the community through follow-up support for up to 3 months.
|
|
Actieve vergelijker: Information only
Participants assigned to the information-only group receive information about health and social services in the community from a non-peer research assistant.
They do not receive peer court navigation or follow-up support from a peer court navigator.
|
Participants assigned to the information-only group receive information about health and social services in the community from a non-peer research assistant.
They do not receive peer court navigation or follow-up support from a peer court navigator.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Administratively documented substance use disorder treatment engagement
Tijdsspanne: 90 days after baseline
|
This participant-level outcome will indicate whether a participant has any administratively documented substance use disorder treatment engagement within 90 days after baseline.
Treatment engagement will be determined from linked state administrative records, including Medicaid claims for substance use disorder treatment services and prescription drug monitoring program records showing dispensed medications used to treat substance use disorder.
For participants without administratively documented substance use disorder treatment during the 90 days before baseline, a qualifying post-baseline record will be classified as treatment initiation.
For participants with administratively documented substance use disorder treatment during the 90 days before baseline, a qualifying post-baseline record will be classified as continued treatment engagement.
The outcome will be reported as the proportion of participants in each study arm with administratively documented treatment engagement.
|
90 days after baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Number of participants with a fatal or nonfatal overdose
Tijdsspanne: 12 months after baseline
|
Fatal and nonfatal overdose will be measured using statewide vital records and emergency medical records from ambulance services and hospital emergency departments.
Participants will be classified as having experienced an overdose if records show a fatal overdose or an encounter for a nonfatal overdose during the 12 months after baseline.
|
12 months after baseline
|
|
Number of participants with a jail booking or prison entry
Tijdsspanne: 12 months after baseline
|
Incarceration through jail booking or prison entry will be measured using statewide criminal legal records.
Participants will be classified as having experienced incarceration if records show a booking into a jail facility or entry into the state prison system during the 12 months after baseline.
|
12 months after baseline
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Medewerkers
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Geschat)
1 oktober 2026
Primaire voltooiing (Geschat)
1 december 2028
Studie voltooiing (Geschat)
1 mei 2030
Studieregistratiedata
Eerst ingediend
3 juli 2026
Eerst ingediend dat voldeed aan de QC-criteria
10 juli 2026
Eerst geplaatst (Werkelijk)
14 juli 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
14 juli 2026
Laatste update ingediend die voldeed aan QC-criteria
10 juli 2026
Laatst geverifieerd
1 juli 2026
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- R01DA064492 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
JA
Beschrijving IPD-plan
The investigators will enroll 600 subjects over 24 months with 12 months of follow-up data by linking administrative records (e.g., prescription fills, emergency department/emergency medical services encounters, mortality, arrests/jail bookings) to survey contents that will include demographics, substance use disorder and treatment history, criminal legal system involvement, social constructs (self-efficacy, motivation, stigma), and harmonized measures.
The National Institutes of Health requires that the study team release study data.
The investigators will preserve and share de-identified survey datasets (with codebooks), and project documentation (protocols, instruments); derived variables from linked administrative data will be shared, while raw state administrative source files obtained under data use agreements will not be shared.
The publicly released scientific data will include only fully de-identified data.
IPD-tijdsbestek voor delen
IPD and additional supporting information will be archived in the National Addiction & HIV Data Archive Program (NAHDAP), assigned persistent identifiers, and made available as soon as possible and no later than the earlier of the primary publication or the end of the performance period, whichever comes first.
IPD-toegangscriteria voor delen
After project completion, only de-identified datasets will be made available as public-use files and deposited in repositories for broader research, teaching, replication.
Shared data will be provided in open, non-proprietary formats, along with parallel Stata/R scripts and a README so that no specialized software is required to access or manipulate the data.
Publicly shared datasets will receive a DOI to facilitate sharing, citation, and version control.
Access will be controlled when there is any non-trivial re-identification risk or when required by data use agreements.
In those cases, repositories will gate access under standard data use agreements that prohibit re-identification and onward sharing, require secure storage and destruction at project end, and log requestor credentials and approved uses.
Raw state administrative source files received under data use agreements will not be shared; only de-identified, derived variables constructed from those sources will be deposited.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .